161 related articles for article (PubMed ID: 20503107)
1. MDM2 309 T/G polymorphism is associated with colorectal cancer risk especially in Asians: a meta-analysis.
Fang F; Yu XJ; Yu L; Yao L
Med Oncol; 2011 Dec; 28(4):981-5. PubMed ID: 20503107
[TBL] [Abstract][Full Text] [Related]
2. An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk.
Qin X; Peng Q; Tang W; Lao X; Chen Z; Lai H; Deng Y; Mo C; Sui J; Wu J; Zhai L; Yang S; Li S; Zhao J
PLoS One; 2013; 8(9):e76031. PubMed ID: 24098760
[TBL] [Abstract][Full Text] [Related]
3. MDM2 309T>G polymorphism and risk of squamous cell carcinomas of head and neck: a meta-analysis.
Liu J; Zheng Y; Lei D; Liu D; Xu F; Jin T; Cao X; Zhao X; Yu X; Pan X
Asian Pac J Cancer Prev; 2011; 12(8):1899-903. PubMed ID: 22292622
[TBL] [Abstract][Full Text] [Related]
4. [Genetic polymorphism in MDM2 is associated with susceptibility to colorectal cancer in a Chinese population].
Liu JN; Zhang XM; Guo YL; Sun T; Lin DX; Wen T
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):335-8. PubMed ID: 18953830
[TBL] [Abstract][Full Text] [Related]
5. Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk.
Fu Q; Zhang G; Chen H; Zheng Y; Cheng J
Tumour Biol; 2013 Dec; 34(6):3721-9. PubMed ID: 23912932
[TBL] [Abstract][Full Text] [Related]
6. MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis.
Liu GY; Jiang DK; Shen SQ; Yu L
Arch Med Res; 2011 Feb; 42(2):149-55. PubMed ID: 21565629
[TBL] [Abstract][Full Text] [Related]
7. Association between the MDM2 T309G polymorphism and leukemia risk: a meta-analysis.
Yan YL; Han F; Tan WM; Wu CP; Qin X
Asian Pac J Cancer Prev; 2014; 15(16):6767-72. PubMed ID: 25169523
[TBL] [Abstract][Full Text] [Related]
8. The MDM2 309T>G polymorphism and ovarian cancer risk: a meta-analysis of 1534 cases and 2211 controls.
Ma YY; Guan TP; Yao HB; Yu S; Chen LG; Xia YJ; He XJ; Wang HJ; Jiang XT; Tao HQ
PLoS One; 2013; 8(1):e55019. PubMed ID: 23383041
[TBL] [Abstract][Full Text] [Related]
9. The MDM2 SNP309T>G polymorphism increases bladder cancer risk among Caucasians: a meta-analysis.
Wang HG; Wu QY; Zhou H; Peng XS; Shi MJ; Li JM; Zhou YF
Asian Pac J Cancer Prev; 2014; 15(13):5277-81. PubMed ID: 25040988
[TBL] [Abstract][Full Text] [Related]
10. MDM2 SNP309 polymorphism is associated with colorectal cancer risk.
Wang W; Du M; Gu D; Zhu L; Chu H; Tong N; Zhang Z; Xu Z; Wang M
Sci Rep; 2014 May; 4():4851. PubMed ID: 24797837
[TBL] [Abstract][Full Text] [Related]
11. MDM2 309 T/G polymorphism is associated with lung cancer risk among Asians.
Gui XH; Qiu LX; Zhang HF; Zhang DP; Zhong WZ; Li J; Xiao YL
Eur J Cancer; 2009 Jul; 45(11):2023-6. PubMed ID: 19264476
[TBL] [Abstract][Full Text] [Related]
12. Current evidence on the relationship between murine double minute 2 T309G polymorphism and esophageal cancer susceptibility.
Chen B; Xiong MM; Meng XL
Dis Esophagus; 2015; 28(6):593-601. PubMed ID: 24844868
[TBL] [Abstract][Full Text] [Related]
13. MDM2 SNP309 variation increases cervical cancer risk among Asians.
Zhuo X; Ren J; Li D; Wu Y; Zhou Q
Tumour Biol; 2014 Jun; 35(6):5331-7. PubMed ID: 24532430
[TBL] [Abstract][Full Text] [Related]
14. Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls.
Zhuo W; Zhang L; Zhu B; Ling J; Chen Z
PLoS One; 2012; 7(7):e41546. PubMed ID: 22844496
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies.
Elshazli RM; Toraih EA; Elgaml A; Kandil E; Fawzy MS
Gene; 2020 Apr; 734():144391. PubMed ID: 32001373
[TBL] [Abstract][Full Text] [Related]
16. Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer.
Leu JD; Wang CY; Tsai HY; Lin IF; Chen RC; Lee YJ
Oncol Rep; 2011 Jun; 25(6):1755-63. PubMed ID: 21479369
[TBL] [Abstract][Full Text] [Related]
17. Association between murine double minute 2 T309G polymorphism and risk of liver cancer.
Tang T; Song X; Yang Z; Huang L; Wang W; Tan H
Tumour Biol; 2014 Nov; 35(11):11353-7. PubMed ID: 25119589
[TBL] [Abstract][Full Text] [Related]
18. Association between MDM2 promoter SNP309 T/G polymorphism and liver cancer risk - a meta-analysis.
Ma HB; Huang T; Han F; Chen WY
Asian Pac J Cancer Prev; 2012; 13(6):2841-6. PubMed ID: 22938470
[TBL] [Abstract][Full Text] [Related]
19. The MDM2 309 T/G polymorphism is associated with head and neck cancer risk especially in nasopharyngeal cancer: a meta-analysis.
Zhang Y; Bai Y; Zhang Y; Guan J; Chen L
Onkologie; 2012; 35(11):666-70. PubMed ID: 23147543
[TBL] [Abstract][Full Text] [Related]
20. Murine double minute 2 rs2279744 polymorphism and hepatocellular carcinoma risk in East Asians: a meta-analysis.
Liu Y; Kuang S; Zheng J; Zheng J; Jin H; Chen S; Jian Z
Tumour Biol; 2014 Feb; 35(2):961-5. PubMed ID: 24061636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
